Somerville K W, Ellis W R, Whitten B H, Balfour T W, Bell G D
Postgrad Med J. 1985 Apr;61(714):313-6. doi: 10.1136/pgmj.61.714.313.
Thirty-one patients with radiolucent common bile duct stones received medical treatment. Nineteen had Rowachol, a terpene preparation, eight (42%) achieving complete stone disappearance within 3 to 48 months. Fifteen (including 3 of the above) took Rowachol with bile acid (chenodeoxycholic in 11, ursodeoxycholic in 4) for 3 to 60 months: 11 (73%) achieved complete dissolution within 18 months. Persistent symptoms and complications settled on conservative management: 8 (25%) patients required admission (2 biliary colic, 1 obstructive jaundice, 4 cholangitis, 1 pancreatitis). One patient died of a myocardial infarction during recovery from pancreatitis; the other continued treatment, 2 achieving complete dissolution/disappearance. Oral dissolution therapy with Rowachol and bile acids should be considered when endoscopic sphincterotomy or surgery is not feasible, but careful attention to potential complications is required while stones persist.
31例胆总管透X线结石患者接受了药物治疗。19例服用萜烯制剂消旋薄荷脑,其中8例(42%)在3至48个月内结石完全消失。15例(包括上述3例)同时服用消旋薄荷脑和胆汁酸(11例服用鹅去氧胆酸,4例服用熊去氧胆酸)3至60个月:11例(73%)在18个月内结石完全溶解。持续的症状和并发症通过保守治疗得到缓解:8例(25%)患者需要住院治疗(2例胆绞痛,1例梗阻性黄疸,4例胆管炎,1例胰腺炎)。1例患者在胰腺炎恢复过程中死于心肌梗死;另1例继续治疗,2例结石完全溶解/消失。在内镜括约肌切开术或手术不可行时,应考虑使用消旋薄荷脑和胆汁酸进行口服溶石治疗,但在结石持续存在时需要密切关注潜在并发症。